Dr. Straus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
525 East 72nd Street
18G
New York, NY 10021Phone+1 646-207-0455
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1975 - 1977
- Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1972 - 1973
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1969 - 1972
- Medical College of WisconsinClass of 1969
Certifications & Licensure
- CA State Medical License 1974 - Present
- FL State Medical License 2022 - Present
- NY State Medical License 1970 - 2025
- NJ State Medical License Active through 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Cancer Docters Newsweek, 2015
- Top Doctors Castle Connolly, 2015
- Super Doctor SuperDoctors.com
Clinical Trials
- Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy Start of enrollment: 1997 Dec 01
- Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma Start of enrollment: 2000 Jan 01
- St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Start of enrollment: 1999 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 67 citationsAdjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low‐grade and intermediate‐grade non‐Hodgkin lympho...Joachim Yahalom, George Varsos, Zvi Fuks, B S Jane Myers, Bayard D. Clarkson
Cancer. 1993-04-01 - 322 citationsA 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a pr...Craig H. Moskowitz, Stephen D. Nimer, Andrew D. Zelenetz, Tania Trippett, Eric Hedrick
Blood. 2001-02-01 - 299 citationsRituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphomaTarun Kewalramani, Andrew D. Zelenetz, Stephen D. Nimer, Carol S. Portlock, David J. Straus
Blood. 2004-05-15
Journal Articles
- CALBG 50604: Risk-Adapted Treatment of Non-Bulky Early Stage Hodgkin Lymphoma Based on Interim PETDavid J Straus, Heiko Schoder, Bruce D Cheson, John C Grecula, Lale Kostakoglu, Eric D Hsi, Leslie L Popplewell, John P Leonard, Craig H Moskowitz, Brad S Kahl, Jonath..., Blood
Abstracts/Posters
- Genomic Profiling of Mantle Cell Lymphoma Suggests Poor-Risk Profile Is Present at Diagnosis and Does Not Arise By Tumor EvolutionDavid J. Straus, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Long-Term Follow-up Confirms Durability of Single-Agent Brentuximab Vedotin As Pre-Transplant Salvage for Classical Hodgkin LymphomaDavid J. Straus, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Central Nervous System Prophylaxis with High-Dose Intravenous Methotrexate or Intrathecal Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma and High-Risk of ...David J. Straus, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Brentuximab vedotin with chemotherapy for stage 3/4 classical Hodgkin lymphoma: Three-year update of the ECHELON-1 study.2019 ASCO Annual Meeting - 6/1/2019
- Brentuximab Vedotin with Chemotherapy in Adolescents and Young Adults (AYA) with Stage III or IV Hodgkin Lymphoma: A Subgroup Analysis from the Phase 3 Echelon-1 Study2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Improving outcomes with brentuximab vedotin (BV) plus chemotherapy in patients with newly diagnosed advanced stage Hodgkin lymphoma.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: